Suchergebnisse - "Soria, J C"

PubPharm (426)

1

Precision medicine in the era of multi-omics : can the data tsunami guide rational treatment decision?

enthalten in: ESMO open | 2023

von Aldea, M. | Friboulet, L. | Apcher, S. | +6

2

Inequality factors in access to early-phase clinical trials in oncology in France : results of the EGALICAN-2 study

enthalten in: ESMO open | 2023

von Charton, E. | Baldini, C. | Fayet, Y. | +21

3

Clinical utility of circulating tumor DNA sequencing with a large panel : a National Center for Precision Medicine (PRISM) study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Bayle, A. | Belcaid, L. | Aldea, M. | +31

CommentIn: Ann Oncol. 2023 Apr;34(4):333-335. - PMID 36804455

4

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Peyraud, F. | Guégan, J. | Bodet, D. | +20

5

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Bessede, A. | Marabelle, A. | Guégan, J. | +14

CommentIn: Ann Oncol. 2022 Sep;33(9):855-856. - PMID 35764272

6

Access to early-phase clinical trials in older patients with cancer in France : the EGALICAN-2 study

enthalten in: ESMO open | 2022

von Baldini, C. | Charton, E. | Schultz, E. | +19

7

Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Chen, J. | Facchinetti, F. | Braye, F. | +19

8

Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors : first-in-human dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Gazzah, A. | Bedard, P. | Hierro, C. | +9

9

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer : updated analysis from the phase II ROAR basket study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Subbiah, V. | Kreitman, R. | Wainberg, Z. | +11

10

Increasing global accessibility to high-level treatments for cervical cancers

enthalten in: Gynecologic oncology | 2022

von Chargari, C. | Arbyn, M. | Leary, A. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]